Csl Ltd ADR
(CSLLY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSLLY | REGN | ARGX | ||
| Company | Csl Ltd ADR | Regeneron Pharmaceuticals | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 64.6200 | 769.63 | 814.66 | ||
| High | 65.8200 | 786.99 | 832.90 | ||
| Low | 61.1100 | 764.78 | 810.74 | ||
| Latest | 64.2200 | 785.51 | 811.45 | ||
| Change | +1.2100 | +18.88 | -8.86 | ||
| % Change | +1.92% | +2.46% | -1.08% | ||
| Volume | 210,000 | 671,600 | 375,200 | ||
| 20-Day Average Volume | 150,860 | 898,710 | 404,255 | ||
| Previous Close | 63.0100 | 766.63 | 820.31 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 61.3432 | 758.10 | 823.90 | ||
| 20-Day Raw Stochastic | 72.88% | 65.35% | 36.67% | ||
| 20-Day Relative Strength | 59.91 | 58.18 | 44.53 | ||
| Weighted Alpha | -22.00 | +25.07 | +28.60 | ||
| Today's Opinion | 24% Sell | 80% Buy | 16% Buy | ||
| Previous Opinion | 24% Sell | 88% Buy | 16% Buy | ||
| Last Month's Opinion | 100% Sell | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.02% since 01/30/26 | +5.94% since 01/30/26 | -3.46% since 01/30/26 | ||
| Low | 61.1100 on 02/06/26 | 731.51 on 02/02/26 | 810.74 on 02/06/26 | ||
| High | 66.6800 on 02/03/26 | 790.00 on 02/05/26 | 861.72 on 02/05/26 | ||
| 1-Month | |||||
| %Chg | +12.12% since 01/06/26 | +1.16% since 01/06/26 | +0.96% since 01/06/26 | ||
| Low | 57.2600 on 01/07/26 | 718.38 on 01/20/26 | 770.67 on 01/12/26 | ||
| High | 66.6800 on 02/03/26 | 821.11 on 01/09/26 | 881.89 on 01/27/26 | ||
| 3-Month | |||||
| %Chg | +10.86% since 11/06/25 | +21.43% since 11/06/25 | -4.65% since 11/06/25 | ||
| Low | 55.3600 on 01/06/26 | 640.99 on 11/07/25 | 770.67 on 01/12/26 | ||
| High | 66.6800 on 02/03/26 | 821.11 on 01/09/26 | 934.62 on 12/03/25 | ||
| 6-Month | |||||
| %Chg | -26.70% since 08/06/25 | +41.50% since 08/06/25 | +20.55% since 08/06/25 | ||
| Low | 54.1000 on 10/29/25 | 541.00 on 10/13/25 | 631.47 on 08/11/25 | ||
| High | 89.5470 on 08/18/25 | 821.11 on 01/09/26 | 934.62 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 62,312,860 | 82,556,312 | 50,214,956 | ||
| Shares Outstanding, K | 970,303 | 105,099 | 61,883 | ||
| Annual Sales | 15,558,000,000 | 14,342,900,000 | 2,252,040,000 | ||
| Annual Net Income | 3,002,000,000 | 4,504,900,000 | 833,040,000 | ||
| Last Quarter Sales | N/A | 3,884,300,000 | 1,151,340,000 | ||
| Last Quarter Net Income | N/A | 844,600,000 | 344,260,000 | ||
| 60-Month Beta | 0.77 | 0.40 | 0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 11.44 on 01/30/26 | 5.18 on 10/30/25 | ||
| Latest Earnings Date | 08/19/25 | 05/05/26 | 02/26/26 | ||
| Most Recent Dividend | 0.760 on 09/10/25 | 0.880 on 11/20/25 | N/A | ||
| Next Ex-Dividends Date | 09/10/25 | 02/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.25 | 62.71 | ||